
Fight Diabetes, Enjoy an 80’s-Inspired Rom-Com? Yes, please!
Breakthrough T1D to benefit from virtual live premiere of new movie produced by David Henrie and Selena Gomez.

Breakthrough T1D Receives Technology Transformation Award
International Society of Chief Data Officers (isCDO) recognizes Breakthrough T1D’s Sri Mishra for “Transformation of Collaboration from Inwards to Outwards.”

Accelerating Our Mission and Becoming More Volunteer Powered
Our bold vision for the future outlines strategies to drive greater impact to unlock cures and drive research that improves…

Breakthrough T1D and Tandem Diabetes Care Partner to Help Educate, Support the T1D Community
New, national partnership will use Breakthrough T1D’s community-facing platforms to highlight benefits of devices such as insulin pumps, continuous glucose…

A Message to Our Community
Breakthrough T1D is making the following commitments internally and to the T1D community to deliver tangible results for Black Americans…

At ADA, Breakthrough T1D-Funded Research Takes Center Stage (featuring a “Happy Hour” with Dr. Aaron Kowalski)
At the American Diabetes Association’s Scientific Sessions, which was held virtually from June 12-16, scientists presented on some of the…

ADA’s Scientific Sessions: Day 4
The American Diabetes Association’s Scientific Sessions is here! Until June 16, scientists will present some of the most updated topics,…

University of Michigan Establishes Elizabeth Weiser Caswell Diabetes Institute
Named for Breakthrough T1D Research Committee member Elizabeth Caswell, Institute will support diabetes research and development of life-changing diabetes therapies.

ADA’s Scientific Sessions: Day 3
The American Diabetes Association’s Scientific Sessions is here! Until June 16, scientists will present some of the most updated topics,…

Updates from the Teplizumab Trial: You’re Not Going to Believe the Results
Last year, at the American Association for Diabetes (ADA) Scientific Sessions, a drug, called teplizumab, was able to significantly delay—for…